Uncategorized

Medical Cannabis Across Europe: Why Patient Access Still Varies by Country Medical cannabis has become an increasingly important subject in European healthcare, pharmaceutical regulation and public policy. Yet despite growing discussion about cannabis-based treatments, patients across Europe do not all have the same opportunities to obtain them. Eligibility rules, prescribing arrangements, approved medicines, supply systems

EU CBD Safety Decisions: Why Some Novel Food Applications Face Different Outcomes Last reviewed: 22 October 2026 Why can one cannabidiol (CBD) application progress through a scientific assessment while another is stopped or receives an inconclusive safety opinion? The answer lies in the evidence submitted, the exact ingredient being assessed and the legal requirements for

EU Hemp Rules vs Ireland: Could a Court Challenge Change the Industry? Last reviewed: 22 October 2026 The debate over EU hemp rules vs Ireland has become one of the most closely watched legal issues facing Europe’s industrial hemp sector. At the centre of the dispute is a fundamental question: can a country treat low-THC

CBD in the UK: Novel Food Rules, Authorisations and What Retailers Need to Know Last reviewed: October 2026 CBD has become a familiar ingredient in the UK wellness market, appearing in oils, capsules, drinks and other consumer products. However, selling CBD is not simply a matter of sourcing an ingredient, designing a label and opening

UK Industrial Hemp Reform: What Could Change in 2026? UK industrial hemp reform is back in the spotlight following a new industry report launched at the Houses of Parliament in October 2026. The Cannabis Industry Council says the UK could make greater use of industrial hemp in agriculture, sustainable construction and domestic manufacturing, but argues

UK Cannabis Law 2026: Current Rules, Medical Access and What Could Change UK cannabis law 2026 remains an important topic for readers following British drug policy, medical cannabis access and possible regulatory developments. Cannabis remains a Class B controlled drug under the Misuse of Drugs Act 1971, while cannabis-based products can be prescribed for medicinal

London Pound Cake vs Wedding Cake en España: diferencias de aroma, sabor y perfil London Pound Cake vs Wedding Cake en España es una comparación interesante para quienes investigan variedades de cannabis conocidas por sus perfiles aromáticos dulces, sus notas de postre y sus matices terrosos. Aunque ambas suelen asociarse con aromas intensos y características

RS11 vs Zoap: diferencias de genética, aroma y perfil La comparación RS11 vs Zoap en España permite explorar dos variedades modernas de cannabis que suelen aparecer en conversaciones sobre perfiles aromáticos complejos. RS11, también conocida como Rainbow Sherbert #11 en muchas referencias, se asocia habitualmente con notas dulces, afrutadas, florales y ligeramente cremosas. Zoap suele

Mimosa vs Tangie: diferencias de genética, aroma y perfil La comparación Mimosa vs Tangie en España permite explorar dos variedades de cannabis que suelen relacionarse con aromas cítricos y afrutados, pero cuyas descripciones presentan diferencias interesantes. Mimosa suele asociarse con notas de naranja, mandarina, fruta dulce y matices tropicales, mientras que Tangie se caracteriza habitualmente